Download Citation
Article Source:
Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer
Mrozek EM,
Bajaj V,
Guo Y,
Malinowska IA,
Zhang J,
et al.
(2021)
Evaluation of Hsp90 and mTOR inhibitors as potential drugs for the treatment of TSC1/TSC2 deficient cancer.
PLOS ONE 16(4): e0248380.
https://doi.org/10.1371/journal.pone.0248380